Schultes Birgit C
SEC CIK 2051419 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | EVP, CSO | 137.7K | — | $78.9K | 4 | 2025-03-01 | 2026-03-01 |
Most active insiders at NTLA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEONARD JOHN M | Pres, CEO, Dir | — | $1.44M |
| 2 | Cohen Fred E | Dir | $1.40M | — |
| 3 | Dulac Edward J III | EVP, CFO | — | $234.2K |
| 4 | BASTA JAMES | EVP, GC | — | $112.4K |
| 5 | Lebwohl David | EVP, Chief Medical Off | — | $109.6K |
| 6 | Dube Michael P | VP, CAO | — | $104.4K |
| 7 | Clark Eliana | EVP, Chief Technical Off | — | $96.0K |
| 8 | Schultes Birgit C | EVP, CSO | — | $78.9K |
| 9 | Bhanji Muna | Dir | — | — |
| 10 | Keresty Georgia | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-01 | NTLA | Intellia Therapeutics, Inc. | Schultes Birgit C | EVP, CSO | A - Grant | $0.00 | +39.2K | 137.7K | +40% | $0 |
| 2026-01-07 | 2026-01-05 | NTLA | Intellia Therapeutics, Inc. | Schultes Birgit C | EVP, CSO | S - Sale | $9.21 | -8,508 | 98.5K | -8% | -$78.4K | |
| 2025-10-03 | 2025-10-01 | NTLA | Intellia Therapeutics, Inc. | Schultes Birgit C | EVP, CSO | S - Sale | $17.38 | -31 | 105.2K | -0.0% | -$538.78 | |
| D | 2025-03-04 | 2025-03-01 | NTLA | Intellia Therapeutics, Inc. | Schultes Birgit C | EVP, CSO | A - Grant | $0.00 | +37.6K | 105.2K | +56% | $0 |
Purchase Sale Sale after option exercise All abbreviations